
Barclays Research Expects AI to Recast Global Supply Chains and Labor Markets
LONDON--(BUSINESS WIRE)--In this year's edition of the Equity Gilt Study, Barclays Research analysts delve into the transformational power of AI, offering a long-term view on how AI-driven disruption and other structural forces are likely to shape the global economy in the years ahead. Beyond the technological shifts, analysts find that AI will accelerate major changes across supply chains, labor markets and the future of work.
'AI is already changing many aspects of the modern economy and financial markets and will continue to do so for years to come,' says Ajay Rajadhyaksha, Global Chairman of Research. "The end result promises to be fascinating – and most likely a net positive for the world at large.'
The Geopolitics of Minerals and Minds
Barclays Research highlights the strategic vulnerabilities created by the global reliance on a handful of countries for critical rare earth elements and skilled talent. Barclays analysts warn that this concentration threatens supply chain stability amid rising geopolitical tensions, trade disputes and climate-related shocks.
AI and the New Skills Divide
Drawing on eight years of data, Barclays analysts find that while AI's overall effect on employment remains modest, it is already reshaping expectations of skills and tasks, especially in higher-paid, white-collar roles. As adoption accelerates, the potential for broader macroeconomic effects continues to grow.
AI's Market Divide
Barclays analysts argue that the spread of AI could have far-reaching implications for investment returns, drawing parallels to past technological revolutions such as the post-WW2 revolution in durable goods, the rise of the internet in the 1990s and the data boom of the 2010s. AI could drive gains in equities, upward pressure on yields across the curve and a moderately stronger dollar.
Deep Impact
The sudden emergence of DeepSeek from China was a 'Sputnik moment' for the US and other developed markets, galvanizing a new wave of investment in AI infrastructure. Barclays analysts believe that the capital expenditure arms race has further to run, not least due to the vast computing power needed for emerging, multi-step workloads.
Notes to editors:
Barclays Equity Gilt Study is a flagship annual publication that combines market-leading macro analysis with a unique multi-asset dataset spanning over 100 years. It provides uniquely rich data and commentary on long-term asset returns in the UK and US. Data for the UK goes back to 1899, while the US data, provided by the Center for Research in Security Prices at the University of Chicago, runs from 1925.
About Barclays Investment Bank
Our vision is to be the UK-centred leader in global finance. We are a diversified bank with comprehensive UK consumer, corporate and wealth and private banking franchises, a leading global investment bank and a strong, specialist US consumer bank. Through these five divisions, we are working together for a better financial future for our customers, clients and communities. The Investment Bank helps money managers, financial institutions, governments, supranational organisations and corporate clients manage their funding, investing, financing, and strategic and risk management needs. www.barclays.com/ib
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
HIVE Digital Capacity Crosses 10 EH/s in May, Aims to More Than Double That by Year-End
Bitcoin miner HIVE Digital Technologies (HIVE) has surpassed 10 exahash per second (EH/s) in hashrate capacity, a 58% increase from April, driven by the launch of a 100-megawatt hydro-powered site in Paraguay. The company said in a press release on Friday that it's on track to reach 25 EH/s by the end of 2025. The firm mined 139 bitcoin in May, or an average rate of 4.5 BTC per day. Peak capacity hit 10.4 EH/s while average hashrate for the month stood at 8.5 EH/s. HIVE said its fleet efficiency remained steady at around 20 joules per terahash (J/TH), and its network share now exceeds 1% of global Bitcoin mining power. The new facility in Paraguay reflects a broader trend in the mining industry: the race to deploy next-generation ASIC miners rapidly and at scale in regions with abundant renewable power. Co-founder Frank Holmes emphasized the company's speed and flexibility, pointing to its Buzz HPC division, which supports AI cloud infrastructure alongside Bitcoin mining. CEO Aydin Kilic said the company's goal for the summer is 18 EH/s, and that fleet upgrades should allow for a daily BTC output of over 12 by the fourth quarter — potentially at a production cost below $50,000 per coin. HIVE operates facilities in Canada, Sweden and Paraguay, powered entirely by hydroelectricity. The company was the first publicly listed crypto miner on the TSX Venture Exchange in 2017. HIVE shares are higher by 13% in New York trade on Friday as the mining sector rallies alongside bitcoin's gain to above $105,000.


Business Insider
an hour ago
- Business Insider
Barclays Reaffirms Their Buy Rating on Arista Networks (ANET)
Barclays analyst Tim Long reiterated a Buy rating on Arista Networks (ANET – Research Report) today and set a price target of $119.00. The company's shares opened today at $96.11. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Long covers the Technology sector, focusing on stocks such as Apple, Motorola Solutions, and Arista Networks. According to TipRanks, Long has an average return of 13.7% and a 62.39% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Arista Networks with a $109.38 average price target, representing a 13.81% upside. In a report released on May 30, Evercore ISI also maintained a Buy rating on the stock with a $105.00 price target.

Associated Press
an hour ago
- Associated Press
Oncoscope Officially Launches, Ushering in a New Era of Real Time Oncology Intelligence
06/06/2025, Miami, Florida // PRODIGY: Feature Story // Anna Forsythe, founder of Oncoscope-AI (source: Oncoscope-AI) Oncoscope-AI, a revolutionary oncology intelligence platform, has officially launched following a successful beta phase and over a year of strategic development that involved extensive conversations with practicing oncologists. The platform, which delivers real-time, human-curated cancer insights enhanced by artificial intelligence, is now live and available free of charge to verified healthcare professionals worldwide. Founded by Anna Forsythe, a pharmacist, health economist, and seasoned pharmaceutical executive, Oncoscope addresses a critical gap in oncology care. It gives clinicians instant access to the most current treatment data, FDA approvals, and guideline-aligned information, consolidated into one user-friendly platform. 'Doctors do not need more data. They need the right information, at the right time, in a format they can use to make better decisions for their patients,' said Forsythe. 'Oncoscope provides that clarity. It is a living library of oncology, curated by experts and built to save lives.' Unlike generic AI tools or static databases, Oncoscope uses trained AI to scan thousands of oncology publications and filters them through a rigorous, evidence-based framework. Each entry is cross-referenced with clinical guidelines and regulatory approvals to ensure usability and relevance. All of the results are carefully scrutinized by a team of experienced researchers. Currently, the platform supports breast and lung cancer, with prostate, bladder, colon, and rectal modules rolling out in the coming months. The process is intuitive. Physicians answer three clinical questions—cancer stage, genetic markers, and prior treatments—and receive a personalized, actionable summary. Each recommended article includes survival data, progression insights, treatment efficacy, and toxicity, extracted across 32 key clinical parameters. 'The result is something physicians can actually use in the moment,' said Forsythe. 'It takes three clicks to go from a patient in the room to the most up-to-date evidence in the field.' Access to Oncoscope is free for verified healthcare professionals, including physicians, nurses, pharmacists, genetic counselors, and physician assistants. Non-verified users, such as those in finance or consulting, can purchase limited access at a monthly rate, restricted to a single cancer type. This structure reflects the company's commitment to empowering front-line clinicians with better tools—without barriers. Forsythe, who previously founded and sold a successful health economics company serving global pharmaceutical clients, brings a rare combination of clinical, technical, and business expertise to this venture. She sees Oncoscope not only as a tool, but as a mission. 'This platform was born from both professional insight and personal urgency,' she said. 'Too many patients are still receiving outdated treatments, simply because their doctors do not have time to stay current. I realized I had the knowledge, the team, and the experience to fix that.' With a lean team, strategic vision, and a rapidly growing user base, Oncoscope is poised to become a trusted global resource in cancer treatment. 'We are not just a tech company,' said Forsythe. 'We are part of the oncology ecosystem. And we are here to help doctors deliver the best care possible.' For more information, visit Media Contact: Name - Anna Forsythe Email - [email protected] Source published by Submit Press Release >> Oncoscope Officially Launches, Ushering in a New Era of Real Time Oncology Intelligence